Vaccinex, Inc.

Please note: The information displayed on this page might be outdated.
Vaccinex, Inc.: Vaccinex is a privately-held, clinical-stage biotechnology company. Its lead product, pepinemab, is an antibody against semaphorin 4D, a novel immunotherapy target to modulate immune response to solid tumors and chronic inflammation that drives neurodegenerative diseases. Vaccinex has an ongoing Phase 2 trial in non-small cell lung cancer (NSCLC) of pepinemab in combination with Merck KGaA’s avelumab, an immune checkpoint inhibitor, and an advanced Phase 2 trial of single agent pepinemab in Huntington’s Disease.
Based in...
US - Middle Atlantic
Public, USA
Market Cap
1895 Mt. Hope Avenue
Rochester, NY 14620
United States

Company Participants at Solebury Trout Corporate Access Calls - May 11&12

  • Maurice Zauderer, Ph.D., President & CEO

Top 10 Holders of Vaccinex, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Point72 Asset Management LP 6.37 1,425,000 3.63 Stakes 7/15/20
The Vanguard Group, Inc. 1.13 183,779 0.47 Funds 12/31/20
Vanguard Group, Inc. (Subfiler) 0.87 142,297 0.36 13F 9/30/20
Telemetry Investments LLC 0.36 58,300 0.15 13F 9/30/20
Citadel LP 0.28 46,050 0.12 13F 9/30/20
Qube Research & Technologies Ltd. (France) 0.28 45,654 0.12 13F 9/30/20
Wedbush Securities, Inc. 0.19 31,000 0.08 13F 9/30/20
Virtu Financial BD LLC 0.16 26,249 0.07 13F 9/30/20
Oppenheimer & Co., Inc. 0.14 23,543 0.06 13F 9/30/20
Simplex Trading LLC 0.11 18,590 0.05 13F 9/30/20
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.